A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed to establish a conclusive benefit.
Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake.
Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback